Tumor ablation is the process of removal of the tumor tissue or cells with simply invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is an initiate into the tumor in imaging guidance. For tumor ablation process Magnetic Resonance Imaging (MRI) or Ultrasound (US), Computed Tomography (CT), is used to show and position the needle investigate into the tumor.
How Big is The Global Tumor Ablation Market?
The Global Tumor Ablation Market is expected to be around US$ 1281 Million by 2028 at a CAGR of 12.5% in the given forecast period.
The major driving factors of Global Tumor Ablation Market are as follows:
The restraining factors of Global Tumor Ablation Market are as follows:
The Global Tumor Ablation Market is segmented on the lines of its technology, material, end user and regional. Based on technology segmentation it covers radiofrequency ablation, cryoablation, microwave ablation, laser interstitial thermal ablation, high intensity focused ultrasound and others. Under material segmentation it covers liver cancer, kidney cancer, lung cancer, bone cancer, prostate cancer, breast cancer and others. End user segmentation contains cancer specialty clinics, hospitals and others. The Global Tumor Ablation Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Tumor Ablation and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Global Tumor Ablation Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets for Global Tumor Ablation Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Medtronic plc, Integra Life Sciences Holdings Corporation, BTG International Ltd, Boston Scientific Corporation, AngioDynamics, Inc., SonaCare Medical, LLC., BVM Medical Limited, St. Jude Medical, Inc., and EDAP TMS S.A.Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Global Tumor Ablation Market has been segmented as below:
By Technology Analysis
By Material Analysis
By End User Analysis
By Regional Analysis
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Global Tumor Ablation Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global Tumor Ablation Market data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our New Reports :-
Technologies for Long-term Care and Home Healthcare Market
1. Introduction
1.1. Key Take Aways
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Research Methodology
2.2.1. Market Research Process
2.2.2. Research Methodology
2.2.2.1. Secondary Research
2.2.2.2. Primary Research
2.2.2.3. Models for Estimation
2.3. Market Size Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.3. Restraints
5. Tumor Ablation Market, By Mode of Treatment
5.1. Key Points
5.2. Laparoscopic Ablation
5.3. Surgical Ablation
5.4. Percutaneous Ablation
6. Tumor Ablation Market, By Technology
6.1. Key Points
6.2. Radiofrequency (RF) Ablation
6.3. Microwave Ablation
6.4. Cryoablation
6.5. Other Technologies
7. Tumor Ablation Market, By Application
7.1. Key Points
7.2. Lung Cancer
7.3. Kidney Cancer
7.4. Bone Metastasis
7.5. Liver Cancer
7.6. Others
8. Tumor Ablation Market, By Region
8.1. Key Points
8.2. North America
8.2.1. U.S
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. U.K
8.3.3. France
8.3.4. Italy
8.3.5. Spain
8.3.6. Netherlands
8.3.7. Belgium
8.3.8. Rest of Europe
8.4. Asia Pacific
8.4.1. China
8.4.2. India
8.4.3. Japan
8.4.4. Australia
8.4.5. Rest of Asia Pacific
8.5. Rest of World
8.6. Competitive Landscape
8.7. Introduction
8.8. Recent Developments
8.8.1. Mergers & Acquisitions
8.8.2. New Product Developments
8.8.3. Portfolio/Production Capacity Expansions
8.8.4. Joint Ventures, Collaborations, Partnerships & Agreements
8.8.5. Others
9. Company Profile
9.1. Medtronic, PLC.
9.1.1. Company Overview
9.1.2. Product/Service Landscape
9.1.3. Financial Overview
9.1.4. Recent Developments
9.2. Angiodynamics, Inc.
9.2.1. Company Overview
9.2.2. Product/Service Landscape
9.2.3. Financial Overview
9.2.4. Recent Developments
9.3. Healthtronics, Inc.
9.3.1. Company Overview
9.3.2. Product/Service Landscape
9.3.3. Financial Overview
9.3.4. Recent Developments
9.4. Galil Medical, Inc.
9.4.1. Company Overview
9.4.2. Product/Service Landscape
9.4.3. Financial Overview
9.4.4. Recent Developments
9.5. Boston Scientific Corporation
9.5.1. Company Overview
9.5.2. Product/Service Landscape
9.5.3. Financial Overview
9.5.4. Recent Developments
9.6. Neuwave Medical, Inc.
9.6.1. Company Overview
9.6.2. Product/Service Landscape
9.6.3. Financial Overview
9.6.4. Recent Developments
9.7. Edap Tms S.A.
9.7.1. Company Overview
9.7.2. Product/Service Landscape
9.7.3. Financial Overview
9.7.4. Recent Developments
9.8. Mermaid Medical A/S
9.8.1. Company Overview
9.8.2. Product/Service Landscape
9.8.3. Financial Overview
9.8.4. Recent Developments
9.9. Sonacare Medical, LLC
9.9.1. Company Overview
9.9.2. Product/Service Landscape
9.9.3. Financial Overview
9.9.4. Recent Developments
9.10. Misonix, Inc.
9.10.1. Company Overview
9.10.2. Product/Service Landscape
9.10.3. Financial Overview
9.10.4. Recent Developments
The Global Tumor Ablation Market has been segmented as below:
By Technology Analysis
By Material Analysis
By End User Analysis
By Regional Analysis
